| # | Title | Journal | Year | Citations |
|---|
| 1 | EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent | European Urology | 2017 | 2,497 |
| 2 | EAU Guidelines on Renal Cell Carcinoma: 2014 Update | European Urology | 2015 | 2,445 |
| 3 | Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials | European Urology | 2006 | 2,360 |
| 4 | PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2 | European Urology | 2016 | 2,290 |
| 5 | The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours | European Urology | 2016 | 2,211 |
| 6 | Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study | European Urology | 2006 | 2,119 |
| 7 | Prevalence of Kidney Stones in the United States | European Urology | 2012 | 1,883 |
| 8 | Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends | European Urology | 2017 | 1,844 |
| 9 | EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013 | European Urology | 2014 | 1,613 |
| 10 | EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016 | European Urology | 2017 | 1,594 |
| 11 | Epidemiology and Risk Factors of Urothelial Bladder Cancer | European Urology | 2013 | 1,572 |
| 12 | EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent | European Urology | 2021 | 1,545 |
| 13 | EAU Guidelines on Prostate Cancer | European Urology | 2008 | 1,373 |
| 14 | The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours | European Urology | 2016 | 1,323 |
| 15 | EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer | European Urology | 2014 | 1,304 |
| 16 | EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease | European Urology | 2011 | 1,299 |
| 17 | Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2 | European Urology | 2019 | 1,270 |
| 18 | International Variation in Prostate Cancer Incidence and Mortality Rates | European Urology | 2012 | 1,252 |
| 19 | Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer | European Urology | 2017 | 1,241 |
| 20 | EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer | European Urology | 2017 | 1,215 |
| 21 | EAU Guidelines on Renal Cell Carcinoma: The 2010 Update | European Urology | 2010 | 1,179 |
| 22 | EAU Guidelines on Interventional Treatment for Urolithiasis | European Urology | 2016 | 1,166 |
| 23 | European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines | European Urology | 2021 | 1,152 |
| 24 | Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology | European Urology | 2009 | 1,145 |
| 25 | Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data | European Urology | 2005 | 1,083 |
| 26 | EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013 | European Urology | 2013 | 1,053 |
| 27 | A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score | European Urology | 2016 | 1,039 |
| 28 | European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update | European Urology | 2019 | 1,022 |
| 29 | Lower Urinary Tract Symptoms and Male Sexual Dysfunction: The Multinational Survey of the Aging Male (MSAM-7) | European Urology | 2003 | 993 |
| 30 | EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction | European Urology | 2013 | 990 |
| 31 | Complications of Transurethral Resection of the Prostate (TURP)—Incidence, Management, and Prevention | European Urology | 2006 | 984 |
| 32 | Systematic Review and Meta-analysis of Studies Reporting Urinary Continence Recovery After Robot-assisted Radical Prostatectomy | European Urology | 2012 | 961 |
| 33 | European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update | European Urology | 2019 | 936 |
| 34 | Epidemiology of Renal Cell Carcinoma | European Urology | 2019 | 917 |
| 35 | A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma | European Urology | 2011 | 910 |
| 36 | Guidelines on Male Sexual Dysfunction: Erectile Dysfunction and Premature Ejaculation | European Urology | 2010 | 905 |
| 37 | EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines | European Urology | 2014 | 868 |
| 38 | Retropubic, Laparoscopic, and Robot-Assisted Radical Prostatectomy: A Systematic Review and Cumulative Analysis of Comparative Studies | European Urology | 2009 | 866 |
| 39 | Sensitivity, Specificity, and Predictors of Positive 68 Ga–Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis | European Urology | 2016 | 819 |
| 40 | Preoperative Aspects and Dimensions Used for an Anatomical (PADUA) Classification of Renal Tumours in Patients who are Candidates for Nephron-Sparing Surgery | European Urology | 2009 | 818 |
| 41 | The Epidemiology of Renal Cell Carcinoma | European Urology | 2011 | 817 |
| 42 | European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update | European Urology | 2015 | 804 |
| 43 | Systematic Review of Complications of Prostate Biopsy | European Urology | 2013 | 779 |
| 44 | Diagnostic Criteria, Classification, and Nomenclature for Painful Bladder Syndrome/Interstitial Cystitis: An ESSIC Proposal | European Urology | 2008 | 747 |
| 45 | Complications in Percutaneous Nephrolithotomy | European Urology | 2007 | 744 |
| 46 | A Consensus Molecular Classification of Muscle-invasive Bladder Cancer | European Urology | 2020 | 741 |
| 47 | EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction | European Urology | 2015 | 735 |
| 48 | European Association of Urology Guidelines on Male Infertility: The 2012 Update | European Urology | 2012 | 730 |
| 49 | 2004 WHO Classification of the Renal Tumors of the Adults | European Urology | 2006 | 728 |
| 50 | International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality | European Urology | 2015 | 710 |
